The COVID-19 pandemic disrupted elective surgical procedures globally, but its aftermath has seen a resurgence in demand for bioreorbable scaffolds. Patients, prioritizing faster recovery and reduced hospital stays, are increasingly opting for minimally invasive surgeries supported by bioreorbable scaffolds over traditional methods requiring permanent implants. This post-pandemic shift underscores the market’s resilience and aligns with a broader trend toward patient-centric care, driving growth in bioreorbable scaffolds adoption.

Elective procedure delays fueled the rebound. Between 2020 and 2022, global orthopedic surgeries dropped by 45%, but by 2023, bioreorbable scaffold-assisted cases surged by 80%, outpacing traditional implant surgeries. Patients cite reduced recovery time (4–6 weeks vs. 8–10 weeks for non-resorbable implants) and lower infection risks as key reasons. In Spain, a 2023 survey found that 70% of delayed joint replacement patients chose scaffold-based procedures, compared to 40% pre-pandemic. This preference is also evident in dermatology: clinics in Turkey reported a 60% increase in scaffold use for scar repairs as patients avoided invasive options.

Telehealth has accelerated this trend. With virtual consultations rising by 70% globally during the pandemic, patients now research scaffold therapies online, comparing outcomes and clinic offerings. This has boosted awareness; 55% of surveyed orthopedic patients in 2023 expressed interest in bioreorbable scaffolds, up from 30% in 2019. Clinics are adapting, offering pre-procedure webinars to educate patients on scaffold benefits, with France’s Clinique du Sport seeing a 35% rise in inquiries after launching its digital platform.

The post-pandemic momentum is projected to persist. As healthcare systems prioritize reducing hospital congestion, bioreorbable scaffolds—with their outpatient-friendly nature—are poised to grow. By 2025, scaffold-assisted surgeries are expected to account for 40% of all elective procedures, up from 25% in 2020. For stakeholders aiming to capitalize on this recovery, understanding post-pandemic trends in bioreorbable scaffolds demand offers insights into patient preferences, procedural rebound rates, and telehealth integration needs, ensuring alignment with evolving care models.